FORTERRA PLC

Director's Dealing • Mar 25, 2025

National Storage Mechanism | Additional information

RNS Number : 1048C

Forterra plc

25 March 2025

25 March 2025

Forterra plc (the "Company")

Director / PDMR Shareholdings

Following the vesting on 17 March 2025 of share options granted to Executive Directors under the 2022 Deferred Annual Bonus Plan ("DABP"), the Company was notified on the 24 March 2025 that on 20 March 2025 the following exercise and sale transactions took place:

Ben Guyatt, Chief Financial Officer exercised options granted under the DABP as laid out below selling sufficient shares to cover the appropriate tax and national insurance liabilities with the balance being retained.

Name	Status	No. of shares exercised	Sale Date	Number of shares sold	Price	Number of shares retained	Total Shareholding	% of ISC
Ben Guyatt	PDMR	68,093	20/3/2025	32,117	£1.63	35,976	149,698	< 1%

The 2022 DABP awards represent the deferral into ordinary shares of part of the Executive Directors' 2021 bonus entitlements under the rules of the scheme subject to the participant being an employee at the time of vesting. No consideration was paid for the grant of the awards which are structured as nominal (1p) cost options although this sum was waived by the Company on exercise. The number of options exercised also includes a dividend equivalent in addition to the options initially granted in accordance with the rules of the scheme.

No new shares were issued in respect of these transactions with shares being transferred to the individuals from the Forterra Employee Benefit Trust.

The above notification is intended to satisfy the Company's obligations under Article 19 of the Market Abuse Regulations.

Enquiries

Forterra plc:	+44 (0) 1604 707 600
Frances Tock (Company Secretary)
FTI Consulting :	+44 (0) 20 3727 1340
Richard Mountain/Nick Hasell

Further information relating to the Company and its group can be found at www.forterraplc.co.uk .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHPPUACWUPAGWA